Navigation Links
American Regent Resumes Shipment of Injectable Products
Date:5/6/2011

SHIRLEY, N.Y., May 6, 2011 /PRNewswire/ -- American Regent announced today that it had resumed the shipment of its multisource injectable products on May 5, 2011.  Release of products is being prioritized and American Regent is working closely with the FDA Drug Shortage Staff to ensure that supplies of critically needed medications are available for patient care.

Please Note: Products have been shipped and are available from your local Wholesaler or Distributor.

In addition to Venofer® (iron sucrose injection, USP), the following products have been released and shipped:Atropine Sulfate Injection, USPCaffeine Citrate Injection, USPChromic Chloride Injection, USPConcentrated Zinc Sulfate Injection, USPDehydrated Alcohol Injection, USPDopamine HCL Injection, USPDroperidol Injection, USPGlycopyrrolate Injection, USPHydroxyzine HCL Injection, USPIron Dextran Injection, USP (Dexferrum®)L-Cysteine HCL Injection, USPMultitrace® -4 (Trace Elements Injection 4, USP)Multitrace® -4 Concentrate (Trace Elements Injection 4, USP - Concentrate)Multitrace® -5 Concentrate (Trace Elements Injection 5, USP - Concentrate)Neostigmine Methylsulfate Injection, USP  Nitroglycerin Injection, USPPapaverine HCL Injection, USPPhenylephrine HCL Injection, USPPotassium Phosphates Injection, USPSodium Phosphates Injection, USPAmerican Regent can confirm that these products were manufactured in accordance with cGMP and quality requirements and that they meet all USP and other internal monograph and quality release specifications. American Regent is confident in the integrity and quality of these injectable products.

Visit our website at www.americanregent.com for daily updates on product releases and availability or contact our Customer Service Department at: 1-800-645-1706. We apologize for any inconvenience this temporary suspension of manufacturing and distribution has caused. We appreciate the tremendous support that our customers and partners have given us during this period and for your continued loyalty and confidence in our products.

American Regent will continue to work diligently to research, develop and supply quality injectable products, as it has done since 1967.

If you have any questions or need to place an order for an emergency "drop shipment" please contact our Customer Service Department at 1-800-645-1706 or for more information, please visit our website at: www.americanregent.com


'/>"/>

SOURCE American Regent, Inc. & Luitpold Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
2. American Pacific to Release Financial Results and Hold Fiscal 2011 Second Quarter Investor Teleconference
3. American Medical Systems GreenLight HPS® Approved for Use in Japan
4. Christiana Care Breast Center First in Delaware to Earn American College of Radiology Accreditation
5. Plato BioPharma Presenting Poster at the American Thoracic Society Conference
6. Hologic Features New Minimally Invasive Technologies at the American Congress of Obstetricians and Gynecologists Annual Meeting
7. Reportlinker Adds Latin American Markets for Dental Implants, Final Abutments and Computer Guided Surgery 2011 (Argentina, Brazil and Mexico)
8. American Regent Resumes Shipment of VENOFER® (iron sucrose injection, USP)
9. May is Older Americans Month
10. Nonin Medical Announces Mark VanderWerf, Vice President-eHealth, Elected to American Telemedicine Association College of Fellows
11. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):